Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings in CHF25mm for Symetis SA

Executive Summary

Symetis SA (developing transcatheter aortic valve implantation systems) has raised CHF25mm ($25.8mm) through its Series C venture round. Endeavour Vision and NBGI Ventures co-led the financing (each will contribute one board member) and were joined by current shareholders Truffle Capital, Novartis Venture Fund, Wellington Partners, Vinci Capital & Renaissance PME, Banexi Ventures, and BioMedInvest.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies